Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 539

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Thrombolytic Therapy: Current Status

Marder, Victor J., Sherry, Sol·1988·New England Journal of Medicine

Abstract

ONE decade after the Food and Drug Administration approved the plasminogen activators streptokinase and urokinase, thrombolytic therapy is no longer a novel approach to the treatment of thrombotic disease. Originally recommended for the treatment of proximal deep-vein thrombosis and serious pulmonary embolism, this approach is now also used for treating acute peripheral arterial thrombosis and embolisms and acute coronary thrombosis and for unclotting catheters and shunts. We are now about to enter the "thrombolytic era" of management of acute myocardial infarction by taking advantage of the readily available and rapid intravenous route instead of the cumbersome intracoronary approach. There have . . .

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm198806093182306

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 539

Metadata

Authors
Marder, V. J., & Sherry, S.
Venue
New England Journal of Medicine
Published
1988-06-09
Volume
318
Issue
23
Pages
1512-1520
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2001563266
Cited by
539
References
1
FWCI
57.59
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Thrombolytic Therapy: Current Status. https://app.cochat.ai/papers/10.1056/nejm198806093182306
The paper
Marder, V. J., & Sherry, S. (1988). Thrombolytic Therapy: Current Status. New England Journal of Medicine. https://doi.org/10.1056/nejm198806093182306

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.